2022
DOI: 10.3389/fneur.2022.834403
|View full text |Cite
|
Sign up to set email alerts
|

Gut Microbiota and Targeted Biomarkers Analysis in Patients With Cognitive Impairment

Abstract: Gut microbial alteration is closely associated with brain disorders including cognitive impairment (CI). Gut microbes have the potential to predicate the development of diseases. However, the gut microbial markers for CI remain to be elucidated. In this study, the gut microbial alterations were assessed using16S rRNA sequencing, and identified the gut microbial markers using a random forest model. The results showed that there were significant gut microbial differences between the control and CI groups based o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
19
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(25 citation statements)
references
References 40 publications
0
19
0
Order By: Relevance
“…Recent studies have shown that intestinal microbes drive liver inflammatory stimuli through the "gut-liver axis" to accelerate liver carcinogenesis [22,23].In addition, gut microbiome can influence the development and progression of hepatocellular carcinoma by regulating the expression and accumulation of immune cells [24]. Studies have demonstrated that gut microbes can be used as noninvasive diagnostic markers for liver cancer, colorectal cancer, type 2 diabetes, and cognitive impairment [25][26][27][28]. However, the potential of gut microbes as biomarkers in clinical HCC patients has not been reported.…”
Section: Introductionmentioning
confidence: 99%
“…Recent studies have shown that intestinal microbes drive liver inflammatory stimuli through the "gut-liver axis" to accelerate liver carcinogenesis [22,23].In addition, gut microbiome can influence the development and progression of hepatocellular carcinoma by regulating the expression and accumulation of immune cells [24]. Studies have demonstrated that gut microbes can be used as noninvasive diagnostic markers for liver cancer, colorectal cancer, type 2 diabetes, and cognitive impairment [25][26][27][28]. However, the potential of gut microbes as biomarkers in clinical HCC patients has not been reported.…”
Section: Introductionmentioning
confidence: 99%
“…70 When compared to a control group, the relative abundance of Lachnoclostridium was higher in the cognitive impairment group. 71 This study showed that lower cognitive performance is associated with higher Blautia relative abundances. A previous study also showed higher abundance of Blautia in less physically active adults with insomnia.…”
Section: Discussionmentioning
confidence: 73%
“… 70 When compared to a control group, the relative abundance of Lachnoclostridium was higher in the cognitive impairment group. 71 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There has been significant interest in developing risk assessment methods based on gut microbiome data ( Li et al, 2017 ; Xu et al, 2019 ; Chu et al, 2021 ; Loftus et al, 2021 ; Shen et al, 2021 ; Yao et al, 2021 ). Attempts have also being made to identify gut bacteria as biomarkers of disease ( Yu et al, 2017 ; Loftus et al, 2021 ; Yao et al, 2021 ; Lu et al, 2022 ). For example, Yao et al (2021) proposed the use of Fusobacterium as an indicator for colorectal cancer (detection) based on the results of linear discriminant analysis and effect size, while Lu et al (2022) identified 15 genera, including Lactobacillus , Bifidobacterium , and Akkermansia , using a random forest classification model as biomarkers (targeted biomarkers) for cognitive impairment.…”
Section: Introductionmentioning
confidence: 99%